ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |